pargyline has been researched along with metallothionein in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cherian, MG; Gallant, KR | 1 |
| Cherian, MG; Imura, N; Satoh, M; Shimizu, H | 1 |
| Imura, N; Naganuma, A | 1 |
| Cherian, MG; Chin, JL; Imura, N; Kadhim, SA; Kloth, DM; Naganuma, A; Satoh, M | 1 |
4 other study(ies) available for pargyline and metallothionein
| Article | Year |
|---|---|
Metabolic changes in glutathione and metallothionein in newborn rat liver.
Topics: Alkynes; Animals; Animals, Newborn; Buthionine Sulfoximine; Cysteine; Female; gamma-Glutamyltransferase; Glutathione; Glycine; Liver; Metallothionein; Methionine Sulfoximine; Pargyline; Pregnancy; Rats; Zinc | 1989 |
Modulation of resistance to anticancer drugs by inhibition of metallothionein synthesis.
Topics: Alkynes; Animals; Cisplatin; Colonic Neoplasms; Cysteine; Doxorubicin; Drug Resistance; Female; Fibrosarcoma; Glycine; Humans; Male; Melphalan; Metallothionein; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Mice, Nude; Pargyline; Sulfates; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Zinc Compounds; Zinc Sulfate | 1994 |
[Role of metallothionein in cancer chemotherapy].
Topics: Alkynes; Animals; Antineoplastic Agents; Bismuth; Cisplatin; Drug Resistance; Female; Glycine; Lung Neoplasms; Melphalan; Metallothionein; Mice; Neoplasms, Experimental; Pargyline | 1994 |
Modulation of both cisplatin nephrotoxicity and drug resistance in murine bladder tumor by controlling metallothionein synthesis.
Topics: Alkynes; Animals; Cisplatin; Cystathionine gamma-Lyase; Drug Resistance; Female; Glutathione; Glycine; Kidney; Metallothionein; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Pargyline; Sulfates; Urinary Bladder Neoplasms; Zinc; Zinc Sulfate | 1993 |